An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
for Schizophrenia
Drug: KarXT
79 locations incl. Phoenix
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 18 - 65
Code: NCT05304767·Phase 3·Recruiting